Value-Based Drug Reviews? US FDA Guidance Emphasizes “Accountability, Communication & Consistency”
Executive Summary
Updated Good Review Management Principles focus exclusively on “fundamental values and operational principles” underpinning the new drug review process – leaving nuts-and-bolts procedures to be spelled out elsewhere.
You may also be interested in...
One Lesson Of The OND Reorg: It Is Hard To Classify Diseases
One goal of proposed overhaul of US FDA’s Office of New Drugs is creating more logical alignment of related diseases within divisions and offices. That is easier said than done.
'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says
US guidances will be shorter and use a series of bullet points to communicate key ideas, replacing the current longer and wordier format.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.